Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study-Reference-Cited by-同舟云学术

Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study

Published:2024-07 Issue: Volume: Page:
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hafeez Shaista^ORCID,Warren-Oseni Karole,Jones Kelly,Mohammed Kabir,El-Ghzal Amir,Dearnaley David,Harris Victoria,Khan Atia,Kumar Pardeep,Lalondrelle Susan,McDonald Fiona,Tan Melissa,Thomas Karen,Thompson Alan,McNair Helen A.,Hansen Vibeke N.,Huddart Robert A.

Funder

National Institute for Health Research

The National Institute for Health Research Biomedical Research Centre for cancer

Cancer Research UK

Publisher

Elsevier BV

Reference56 articles.

1. European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: Summary of the 2020 guidelines;Witjes;Eur Urol,2021

2. National Comprehensive Cancer Network. NCCN Guidelines. version 1. 2023. Muscle invasive bladder cancer. 2023. Accessed February 19, 2023. https://www.nccn.org/professionals/physician_gls/pdf/bladder.pdf

3. National Institute for Health and Clinical Excellence (NICE) Guidance. Bladder cancer: Diagnosis and management. 2015. Accessed February 19, 2023. http://wwwniceorguk/guidance/ng2/evidence/full-guideline

4. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: A multi-institutional propensity score matched and weighted analysis;Zlotta;Lancet Oncol,2023

5. Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group;Coppin;J Clin Oncol,1996